Literature DB >> 7893592

Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.

J Coste1, G Strauch, M Letrait, X Bertagna.   

Abstract

Few data are available on the reliability of measurements of adrenocortical and corticotroph hormones for use in clinical pharmacology. Two placebo controlled cross-over trials in 20 normal healthy male subjects offered the opportunity to perform three repeat samplings of adrenocortical and corticotroph hormones at 1 to 5 week intervals during the placebo periods. Measurements of baseline levels of plasma, salivary and urinary cortisol, plasma adrenocorticotroph hormone (ACTH), lipotrophic hormone (LPH), beta-endorphin, post tetracosactrin levels of plasma and salivary cortisol, post corticotrophin releasing hormone (CRH)-lysine vasopressine (LVP) levels of plasma cortisol, ACTH and LPH; and post metyrapone levels of plasma cortisol and 11-deoxycortisol (compound S), ACTH, LPH, beta-endorphin were performed in the same laboratory. The reliability of the measurements was estimated by computing the intraclass correlation coefficient (R) and by using Altman-Bland graphical method. The Rs of baseline parameters varied from 0.18 (for 08.00 h salivary cortisol) to 0.55 (for 08.00 h plasma cortisol and nocturnal urinary cortisol). In contrast, parameters obtained after direct stimulation or inhibition of the producing targets were much more reliable: Rs were above 0.80 for post tetracosactrin levels of plasma and salivary cortisol, post CRH-LVP levels of plasma ACTH and LPH. The Rs were below 0.50 for post metyrapone levels of plasma 11-deoxycortisol, ACTH, LPH and beta-endorphin. The interval between sampling did not affect R estimates. These data show that peak levels of plasma cortisol and ACTH after direct stimulation are highly reliable whereas baseline and main post-metyrapone levels are not.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893592      PMCID: PMC1364884          DOI: 10.1111/j.1365-2125.1994.tb04386.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

Review 1.  The Cushing syndrome: an update on diagnostic tests.

Authors:  T B Kaye; L Crapo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

Review 2.  Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.

Authors:  D H Streeten; G H Anderson; T G Dalakos; D Seeley; J S Mallov; R Eusebio; F S Sunderlin; S Z Badawy; R B King
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumours.

Authors:  M H Laudat; L Billaud; P Thomopoulos; O Vera; A Yllia; J P Luton
Journal:  Acta Endocrinol (Copenh)       Date:  1988-11

4.  Plasma lipotropin increase in man after growth hormone administration. Comparison between extractive and biosynthetic hormones.

Authors:  J M Kuhn; X Bertagna; D Seurin; M Gourmelen; F Girard
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

  4 in total
  10 in total

Review 1.  Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies.

Authors:  Sherita Hill Golden; Gary S Wand; Saurabh Malhotra; Ihab Kamel; Karen Horton
Journal:  Eur J Epidemiol       Date:  2011-04-30       Impact factor: 8.082

Review 2.  Cushing's syndrome: why is diagnosis so difficult?

Authors:  David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

3.  Shiftwork duration and the awakening cortisol response among police officers.

Authors:  Michael Wirth; James Burch; John Violanti; Cecil Burchfiel; Desta Fekedulegn; Michael Andrew; Hongmei Zhang; Diane B Miller; James R Hébert; John E Vena
Journal:  Chronobiol Int       Date:  2011-05       Impact factor: 2.877

4.  Intra-Individual Consistency in Endocrine Profiles Across Successive Pregnancies.

Authors:  Molly Fox; Curt A Sandman; Elysia Poggi Davis; Laura M Glynn
Journal:  J Clin Endocrinol Metab       Date:  2015-10-20       Impact factor: 5.958

5.  Stability of the diurnal cortisol profile in children and adolescents.

Authors:  Sivan Rotenberg; Jennifer J McGrath; Marie-Helene Roy-Gagnon; Mai Thanh Tu
Journal:  Psychoneuroendocrinology       Date:  2012-06-01       Impact factor: 4.905

6.  Association of the Period3 clock gene length polymorphism with salivary cortisol secretion among police officers.

Authors:  Michael Wirth; James Burch; John Violanti; Cecil Burchfiel; Desta Fekedulegn; Michael Andrew; Hongmei Zhang; Diane B Miller; Shawn D Youngstedt; James R Hébert; John E Vena
Journal:  Neuro Endocrinol Lett       Date:  2013       Impact factor: 0.765

7.  Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity.

Authors:  Johann Steiner; Roland Jacobs; Benjamin Panteli; Mareike Brauner; Kolja Schiltz; Sabine Bahn; Marlis Herberth; Sabine Westphal; Tomasz Gos; Martin Walter; Hans-Gert Bernstein; Aye Mu Myint; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-27       Impact factor: 5.270

Review 8.  Variability in laboratory parameters used for management of Cushing's syndrome.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio
Journal:  Endocrine       Date:  2015-07-10       Impact factor: 3.633

9.  The relationship between dehydroepiandrosterone (DHEA), working memory and distraction--a behavioral and electrophysiological approach.

Authors:  Sónia do Vale; Lenka Selinger; João Martin Martins; Ana Coelho Gomes; Manuel Bicho; Isabel do Carmo; Carles Escera
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

Review 10.  Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review.

Authors:  Richella Ryan; Sara Booth; Anna Spathis; Sarah Mollart; Angela Clow
Journal:  Ann Behav Med       Date:  2016-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.